Endothelin-1 exacerbates lipid accumulation by increasing the protein degradation of the ATP-binding cassette transporter G1 in macrophages

Journal of Cellular Physiology

Volumn 226, Issue 8, 2011, Pages 2198-2205

  Lin, Chun Yueh ^a   Lee, Tzong Shyuan ^a,b   Chen, Chin Chang ^a   Chang, Cheng An ^a   Lin, Yan Jie ^a   Hsu, Yung Pei ^c   Ho, Low Tone ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; CALPAIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; LIPID; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; LIPID STORAGE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CALPAIN; ENDOTHELIN-1; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIPOPROTEINS, LDL; MACROPHAGES; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B;

RATTUS;

EID: 79955086901     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22556     Document Type: Article

References (46)

1. Arakawa R, Tsujita M, Iwamoto N, Ito-Ohsumi C, Lu R, Wu CA, Shimizu K, Aotsuka T, Kanazawa H, Abe-Dohmae S, Yokoyama S. 2009. Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis. J Lipid Res 50: 2299-2305.
2. Babaei S, Picard P, Ravandi A, Monge JC, Lee TC, Cernacek P, Stewart DJ. 2000. Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: Role of endothelin in macrophage foam cell formation. Cardiovasc Res 48: 158-167.
3. Baldan A, Tarr P, Lee R, Edwards PA. 2006. ATP-binding cassette transporter G1 and lipid homeostasis. Curr Opin Lipidol 17: 227-232.
4. Barton M, Haudenschild CC, d'Uscio LV, Shaw S, Munter K, Luscher TF. 1998. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 95: 14367-14372.
5. Beyea MM, Heslop CL, Sawyez CG, Edwards JY, Markle JG, Hegele RA, Huff MW. 2007. Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S), 25-epoxycholesterol. J Biol Chem 282: 5207-5216.
6. Browatzki M, Pfeiffer CA, Schmidt J, Kranzhofer R. 2005. Endothelin-1 induces CD40 but not IL-6 in human monocytes via the proinflammatory transcription factor NF-kappaB. EurJ Med Res 10: 197-201.
7. de Winther MP, Hofker MH. 2000. Scavenging new insights into atherogenesis. J Clin Invest 105: 1039-1041.
8. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL. 2000. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105: 1049-1056.
9. Feng B, Tabas I. 2002. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J Biol Chem 277: 43271-43280.
10. Galkina E, Ley K. 2009. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 27: 165-197.
11. Glass CK, Witztum JL. 2001. Atherosclerosis. The road ahead. Cell 104: 503-516.
12. Haidar B, Denis M, Krimbou L, Marcil M, Genest J, Jr. 2002. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J Lipid Res 43: 2087-2094.
13. Hanna RA, Campbell RL, Davies PL. 2008. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature 456: 409-412.
14. Haug C, Schmid-Kotsas A, Zorn U, Schuett S, Gross HJ, Gruenert A, Bachem MG. 2001. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins. J Mol Cell Cardiol 33: 1701-1712.
15. Iwasa S, Fan J, Shimokama T, Nagata M, Watanabe T. 1999. Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. Atherosclerosis 146: 93-100.
16. Iwasa S, Fan J, Miyauchi T, Watanabe T. 2001. Blockade of endothelin receptors reduces diet-induced hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice. Pathobiology 69: 1-10.
17. Jones GT, van Rij AM, Solomon C, Thomson IA, Packer SG. 1996. Endothelin-1 is increased overlying atherosclerotic plaques in human arteries. Atherosclerosis 124: 25-35.
18. Kennedy MA, Barrera GC, Nakamura K, Baldan A, Tarr P, Fishbein MC, Frank J, Francone OL, Edwards PA. 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 1: 121-131.
19. Klucken J, Buchler C, Orso E, Kaminski WE, Porsch-Ozcurumez M, Liebisch G, Kapinsky M, Diederich W, Drobnik W, Dean M, Allikmets R, Schmitz G. 2000. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA 97: 817-822.
20. Kobayashi T, Miyauchi T, Iwasa S, Sakai S, Fan J, Nagata M, Goto K, Watanabe T. 2000. Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis. Pathol Int 50: 929-936.
21. Koliakos G, Befani C, Paletas K, Kaloyianni M. 2007. Effect of endothelin on sodium/hydrogen exchanger activity of human monocytes and atherosclerosis-related functions. Ann NY Acad Sci 1095: 274-291.
22. Kowala MC, Rose PM, Stein PD, Goller N, Recce R, Beyer S, Valentine M, Barton D, Durham SK. 1995. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. Am J Pathol 146: 819-826.
23. Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S, Rhee JS, Silverstein R, Hoff HF, Freeman MW. 2002. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 277: 49982-49988.
24. Kwok CF, Juan CC, Ho LT. 2007. Endothelin-1 decreases CD36 protein expression in vascular smooth muscle cells. Am J Physiol Endocrinol Metab 292: E648-E652.
25. Lee TS, Lin CY, Tsai JY, Wu YL, Su KH, Lu KY, Hsiao SH, Pan CC, Kou YR, Hsu YP, Ho LT. 2009. Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages. Life Sci 84: 97-104.
26. Li AC, Glass CK. 2002. The macrophage foam cell as a target for therapeutic intervention. Nat Med 8: 1235-1242.
27. Libby P. 2002. Inflammation in atherosclerosis. Nature 420: 868-874.
28. Lusis AJ. 2000. Atherosclerosis. Nature 407: 233-241.
29. Oram JF, Heinecke JW. 2005. ATP-binding cassette transporter A1: A cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 85: 1343-1372.
30. Out R, Hoekstra M, Hildebrand RB, Kruit JK, Meurs I, Li Z, Kuipers F, Van Berkel TJ, Van Eck M. 2006. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 26: 2295-2300.
31. Out R, Hoekstra M, Meurs I, de Vos P, Kuiper J, Van Eck M, Van Berkel TJ. 2007. Total body ABCG1 expression protects against early atherosclerotic lesion development in mice. Arterioscler Thromb Vasc Biol 27: 594-599.
32. Pennings M, Meurs I, Ye D, Out R, Hoekstra M, Van Berkel TJ, Van Eck M. 2006. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett 580: 5588-5596.
33. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. 1990. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735.
34. See RH, Caday-Malcolm RA, Singaraja RR, Zhou S, Silverston A, Huber MT, Moran J, James ER, Janoo R, Savill JM, Rigot V, Zhang LH, Wang M, Chimini G, Wellington CL, Tafuri SR, Hayden MR. 2002. Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux. J Biol Chem 277: 41835-41842.
35. Shimada K, Yonetani Y, Kita T, Suzumura A, Takayanagi T, Nakashima T. 1998. Cyclooxygenase 2 expression by endothelin-1-stimulated mouse resident peritoneal macrophages in vitro. Eur J Pharmacol 356: 73-80.
36. Tsujinaka T, Kajiwara Y, Kambayashi J, Sakon M, Higuchi N, Tanaka T, Mori T. 1988. Synthesis of a new cell penetrating calpain inhibitor (calpeptin). Biochem Biophys Res Commun 153: 1201-1208.
37. Wang Y, Oram JF. 2002. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem 277: 5692-5697.
38. Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY. 1998. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152: 711-720.
39. Wang N, Chen W, Linsel-Nitschke P, Martinez LO, Agerholm-Larsen B, Silver DL, Tall AR. 2003. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J Clin Invest 111: 99-107.
40. Wang N, Lan D, Chen W, Matsuura F, Tall AR. 2004. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high density lipoproteins. Proc Natl Acad Sci USA 101: 9774-9779.
41. Wang N, Ranalletta M, Matsuura F, Peng F, Tall AR. 2006. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscler Thromb Vasc Biol 26: 1310-1316.
42. Witztum JL. 2005. You are right too! J Clin Invest 115: 2072-2075.
43. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
44. Yang Z, Krasnici N, Luscher TF. 1999. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: Effects of ETA and ETB receptor blockade. Circulation 100: 5-8.
45. Ye Q, Chen Y, Lei H, Liu Q, Moorhead JF, Varghese Z, Ruan XZ. 2009. Inflammatory stress increases unmodified LDL uptake via LDL receptor: An alternative pathway for macrophage foam-cell formation. Inflamm Res 58: 809-818.
46. Zingg JM, Ricciarelli R, Azzi A. 2000. Scavenger receptor regulation and atherosclerosis. Biofactors 11: 189-200.